← All trials
NCT04516096
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 22, 2020
- Primary completion
- Jan 31, 2021
- Completion date
- Jan 31, 2023
- First posted
- Aug 18, 2020
- Last posted
- Nov 30, 2020
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Amylyx Pharmaceuticals Inc.Lead sponsor
- Amylyx Pharmaceuticals Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.